Mersana Therapeutics, Inc. Deferred Revenue (Non-Current)
Mersana Therapeutics, Inc. had Deferred Revenue (Non-Current) of $28.77 million as of 2017-12-31, per its 10-K filed 2018-03-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2018-03-28
- 2017-12-31: Deferred Revenue, Noncurrent $28.77M.
- 2017-09-30: Deferred Revenue, Noncurrent $34.63M.
- 2017-06-30: Deferred Revenue, Noncurrent $30.81M.
- 2016-12-31: Deferred Revenue, Noncurrent $37.57M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2017-12-31 | $28.77M 10-K · filed 2018-03-28 |
| 2017-09-30 | $34.63M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $30.81M 10-Q · filed 2017-08-11 |
| 2016-12-31 | $37.57M 10-K · filed 2018-03-28 |